Loading clinical trials...
Loading clinical trials...
This phase II study evaluates the efficacy and safety of neoadjuvant chemoimmunotherapy consisting of camrelizumab (PD-1 inhibitor), paclitaxel, and carboplatin in patients with resectable locally adv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Medical Research Radiological Centre of the Ministry of Health of Russia
NCT07276399 · Squamous Cell Carcinoma of Head and Neck
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT07419464 · Squamous Cell Carcinoma of Head and Neck, Metastatic Squamous Cell Carcinoma, and more
NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more
NCT07455032 · Squamous Cell Carcinoma of Head and Neck
P.A. Hertsen Moscow Oncology Research Institute
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions